Format

Send to

Choose Destination
See comment in PubMed Commons below
Cancer Invest. 2012 Nov;30(9):637-41. doi: 10.3109/07357907.2012.726387. Epub 2012 Sep 28.

The effect of metastatic site and decade of diagnosis on the individual burden of metastatic melanoma: contemporary estimates of average years of life lost.

Author information

1
Duke Comprehensive Cancer Center, Duke University Medical Center (DUMC), Durham, North Carolina 27710, USA.

Abstract

OBJECTIVES:

Metastatic melanoma (MM) is a leading cause of years of life lost due to malignancy. This study aimed to identify the average years of life lost (AYLL) in MM patients.

METHODS:

MM patients were identified from a prospectively maintained database, and a linear model predicting AYLL was developed.

RESULTS:

Between 1970 and 1999, 4,774 patients diagnosed with MM died. The AYLL was 23.2 years. AYLL remained stable across three decades.

CONCLUSIONS:

AYLL for MM is greater than 20 years, and has not improved. This burden underscores the need for continued research and access to funding for this disease.

PMID:
23020583
DOI:
10.3109/07357907.2012.726387
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Support Center